Detalles de la búsqueda
1.
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.
Blood;
139(17): 2601-2621, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35271698
2.
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.
Am J Hematol;
98(11): 1685-1698, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548390
3.
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
Blood;
135(22): 1929-1945, 2020 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32187362
4.
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.
Blood;
133(23): 2465-2477, 2019 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30992265
5.
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Blood;
133(8): 840-851, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563875
6.
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol;
97(9): 1745, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934835
7.
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol;
97(10): 1825-1839, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29862437
8.
Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.
Am J Hematol;
92(10): E567-E574, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28699225
9.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci;
18(2)2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212292
10.
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).
Blood;
121(23): 4769-77, 2013 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23632886
11.
Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies.
Haematologica;
100(8): 997-1004, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26314082
12.
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol;
93(11): 1825-38, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24951123
13.
Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs;
25(7): 848-53, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24667659
14.
Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.
J Clin Microbiol;
51(3): 863-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23269732
15.
Acute myeloid leukemia with TP53 germ line mutations.
Blood;
128(18): 2270-2272, 2016 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27621308
16.
Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center Experience.
Cancers (Basel);
15(24)2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136284
17.
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center Analysis.
Vaccines (Basel);
11(10)2023 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37896938
18.
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia.
Leuk Lymphoma;
63(10): 2330-2335, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35561263
19.
Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Eur J Cancer;
177: 186-193, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368252
20.
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group.
Cancers (Basel);
14(10)2022 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626063